Health 360: Hantavirus on cruise sparks global scare, cancer myths busted and more
Health 360: Hantavirus on cruise sparks global scare, cancer myths busted and more
- 100
- 08
Covishield, the version of AstraZeneca manufactured by Pune-based Serum Institute of India, is not listed by the European Medicines Agency (EMA) for the EU ‘Green Pass' eligibility. Only four vaccines -- Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson's Janssen -- have been approved by the EMA and only those vaccinated by these vaccines will be given vaccination passports and will be allowed to travel within the EU during the pandemic.
Meanwhile, Serum Institute of India has requested the government to take up the matter of inclusion of Covishield vaccine in the EU COVID-19 Vaccination Passport with the European Union and other countries, citing this will affect students and business travellers and cause severe disruptions to the Indian and global economy.
Health 360: Hantavirus on cruise sparks global scare, cancer myths busted and more
Massive fire breaks out at Shahberi furniture market in Greater Noida
Dialogue and diplomacy only solution to West Asia crisis: PM Modi; BRICS divided over West Asia crisis
CBI arrests NEET paper leak 'kingpin' in Pune, NEET re-exam to be held on June 21